1. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy 
Christophe K. Mannaerts, Maudy Gayet, Jan F. Verbeek, Marc R.W. Engelbrecht, C. Dilara Savci-Heijink, Gerrit J. Jager, Maaike P.M. Gielens, Hans van der Linden, Harrie P. Beerlage, Theo M. de Reijke, Hessel Wijkstra, Monique J. Roobol 
European Urology Oncology 
Volume 1, Issue 2, Pages (June 2018)
DOI: /j.euo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
Multiparametric magnetic resonance imaging, targeted biopsy, and systematic biopsy outcomes according to the Rotterdam Prostate Cancer Risk Calculator (RPCRC) biopsy advice. mpMRI=multiparametric resonance imaging; PCa=prostate cancer; SBx=systematic biopsy; TBx=targeted biopsy.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions

3. Fig. 2
(A–C) Multiparametric magnetic resonance imaging, targeted biopsy, and systematic biopsy outcomes according to the Rotterdam Prostate Cancer Risk Calculator (RPCRC) biopsy advice. (mp)MRI=(multiparametric) magnetic resonance imaging; PCa=prostate cancer; SBx=systematic biopsy, TBx=targeted biopsy.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions